Stragenics (ASAB) Inactive 10-Q19 Nov 132013 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2013	Nov. 19, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'ALLERAYDE SAB, INC.	'
Entity Central Index Key	'0001456993	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	89,005,250

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets	'	'
Cash and equivalents	$6,093	$16
Accounts receivable	4,000	0
Total Current Assets	10,093	16
TOTAL ASSETS	10,093	16
Current Liabilities	'	'
Accrued expenses	111,756	3,096
Accrued interest	149,638	0
Convertible notes payable	1,481,978	0
Due to related parties	431,061	0
Loans payable	55,555	0
Total Liabilities	2,229,988	3,096
Stockholders' Deficit	'	'
Preferred Stock Authorized: 100,000,000 preferred shares. No shares issued and outstanding at June 30, 2013 and December 31, 2012	0	0
Common Stock, 400,000,000 shares of common stock with par value of $.0001, (2012 -unlimited shares authorized no par value, Issued 89,005,250 shares of common stock ( 2012- 10 shares issued and outstanding )	8,900	15
Additional paid in capital	460,283	0
Accumulated other comprehensive loss	-1,562	-11
Deficit accumulated during the development stage	-2,687,516	-3,084
Total Stockholders' Deficit	-2,219,895	-3,080
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$10,093	$16

Balance_Sheets_Unaudited_Paren

Balance Sheets (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Balance Sheets [Abstract]	'	'
Preferred Stock, shares authorized	100,000,000	100,000,000
Preferred Stock, shares issued	'	'
Preferred Stock, shares outstanding	'	'
Common Stock, shares authorized	400,000,000	'
Common Stock, par value	$0.00	'
Common Stock, shares issued	89,005,250	10
Common Stock, shares outstanding	89,005,250	10

Statements_of_Operations_and_O

Statements of Operations and Other Comprehensive Loss (Unaudited) (USD $)	3 Months Ended		9 Months Ended		21 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Statements of Operations and Other Comprehensive Loss [Abstract]	'	'	'	'	'
REVENUES	'	$0	$16,289	$0	$16,289
EXPENSES	'	'	'	'	'
Professional fees	2,151	0	7,948	0	10,448
Consulting fees	'	0	50,000	0	50,000
Salaries and benefits	'	0	8,184	0	8,184
Interest on convertible notes	2,005	0	8,362	0	8,362
General and administrative	14,098	0	23,549	0	23,549
Rent	'	0	1,640	0	2,224
TOTAL EXPENSES	18,254	0	99,683	0	102,767
LOSS FROM OPERATIONS	-18,254	0	-83,394	0	-86,478
PROVISION FOR INCOME TAXES	0	0	0	0	0
NET LOSS	-18,254	0	-83,394	0	-86,478
NET LOSS PER SHARE: BASIC AND DILUTED	$0	$0	$0	$0	'
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	89,005,250	0	84,889,000	78,632,792	'
OTHER COMPREHENSIVE LOSS	'	'	'	'	'
Net loss	-18,254	0	-83,394	0	-86,478
Other comprehensive loss	'	'	'	'	'
Foreign currency translation adjustments	-1,651	0	-1,573	0	-1,562
TOTAL COMPREHENSIVE LOSS	($16,603)	$0	($81,821)	$0	($84,916)

Statement_of_Stockholders_Defi

Statement of Stockholders' Deficit (USD $)	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Deficit accumulated during the development stage
Beginning balance at Dec. 31, 2011	'	'	'	'	'
Beginning balance, Shares at Dec. 31, 2011	'	'	'	'	'
Issuance of common stock for cash	15	15	'	'	'
Issuance of common stock for cash, Shares	'	10	'	'	'
Net loss and other comprehensive loss for the period	'	'	'	-11	-3,084
Balance at Dec. 31, 2012	-3,080	15	0	-11	-3,084
Balance, Shares at Dec. 31, 2012	'	10	'	'	'
Cancellation of shares on recapitalization	0	-15	15	'	'
Cancellation of shares on recapitalization, Shares	'	-10	'	'	'
Issuance of shares on recapitalization	0	7,666	-15	'	-7,651
Issuance of shares on recapitalization, Shares	'	76,658,739	'	'	'
Assumption of net liabilities on recapitalization	-2,593,387	'	'	'	-2,593,387
Correction to common stock outstanding	'	'	'	'	'
Correction to common stock outstanding, Shares	'	11	'	'	'
Issuance of common stock for debt	461,517	1,234	460,283	'	'
Issuance of common stock for debt, Shares	'	12,346,500	'	'	'
Net loss and other comprehensive loss for the period	-81,821	'	'	-1,551	-83,394
Balance at Sep. 30, 2013	($2,219,895)	$8,900	$460,283	($1,562)	($2,687,516)
Balance, Shares at Sep. 30, 2013	'	89,005,250	'	'	'

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited)	9 Months Ended		21 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
	USD ($)	USD ($)	USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss for the period	($83,394)	$0	($86,478)
Adjustments to reconciled net loss to net cash provided by operating activities:	'	'	'
Convertible note issued for expenses	54,000	0	54,000
Changes in assets and liabilities:	'	'	'
Increase in accrued expenses	9,522	0	12,618
Net Cash Provided by (Used in) Operating Activities	-19,872	0	-19,860
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from promissory note	27,500	'	27,500
Proceeds from issuance of common stock	0	'	15
Net Cash Provided by Financing Activities	27,500	0	27,515
Exchange rate effect on cash	-1,551	0	-1,562
NET INCREASE (DECREASE) IN CASH	6,077	0	6,093
Cash, beginning of period	16	0	0
Cash, (bank overdraft) end of period	6,093	0	6,093
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'	'
Cash paid for interest	0	0	0
Cash paid for income taxes	0	0	0
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'
Net liabilities acquired on recapitalization	2,593,387	'	2,593,387
Common Stock Issued For Debt	$95,597	'	$95,597

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2013
Summary of Significant Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Nature of Business
	Allerayde SAB, Inc., formerly known as Mobieyes Software, Inc. (the “Company”) was incorporated under the laws of the State of Florida on January 15, 2009. On February 23, 2010, the Company changed its name to Resource Exchange of America Corp. Effective April 30, 2013, the Company changed its name to Allerayde SAB, Inc. The Company’s prior business was a mobile enterprise software company aimed at improving productivity of field service organizations. Upon completion of the acquisition of assets from UTP Holdings, LLC on February 22, 2010, the Company adopted the business of UTP Holdings, LLC. The Company is now engaged in the business of recycling ferrous and nonferrous metals to customers in the United States and abroad.

	On March 21, 2013, the Company entered into a Share Exchange Agreement with Allerayde SAB Limited. (“Allerayde”) and Mike Rhodes, the sole member of Allerayde (the “Allerayde Stockholder”) (the “Share Exchange Agreement”). This share exchange transaction constituted a reverse merger and a recapitalization of Allerayde. In conjunction with this reverse merger, the historical accounts of Allerayde become the historical accounts of Resource Exchange of America Corp for accounting purposes.

	Development Stage Company
	The accompanying financial statements have been prepared in accordance with generally accepted accounting principles related to development-stage companies. A development-stage company is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

	Basis of Presentation
	The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The accompanying interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary in order for the financial statements to be not misleading have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

	Accounting Basis
	The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

	Cash and Cash Equivalents
	Allerayde considers all highly liquid investments with maturities of three months or less to be cash equivalents. At September 30, 2013 and December 31, 2012, respectively, the Company had $6,093 and $16 of cash.

	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents, loans payable, and accrued expenses. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

	Income Taxes
	Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

	Revenue Recognition
	The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

	Foreign Currency
	The operations of the Company are located in England and Wales. Allerayde maintains a Great Britain Pounds bank account. The functional currency is the U.S. Dollar. Transactions in foreign currencies other than the functional currency, if any, are re-measured into the functional currency at the rate in effect at the time of the transaction. Monetary assets and liabilities denominated in Great Britain Pounds are translated into U.S. Dollars at the rate in effect at the balance sheet date. Revenue and expenses denominated in Great Britain Pounds Dollars are translated at the average exchange rate.

	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of September 30, 2013.

	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

	Recent Accounting Pronouncements
	Allerayde does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

Going_Concern

Going Concern	9 Months Ended
Going Concern	Sep. 30, 2013
Going Concern [Abstract]	'
GOING CONCERN	'
	NOTE 2 – GOING CONCERN

	The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception, has an accumulated deficit of $2,687,516 as of September 30, 2013, has a working capital deficit, and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand and loans from directors and or private placement of common stock.

Convertible_Notes_Payable

Convertible Notes Payable	9 Months Ended
Convertible Notes Payable	Sep. 30, 2013
Convertible Notes Payable [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	NOTE 3 – CONVERTIBLE NOTES PAYABLE

	a) On February 22, 2010, the Company issued a $250,000 promissory note to the President of the Company. The note bears interest at 10% per annum, is unsecured, and was due on December 31, 2011. The holder may convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the five trading days immediately preceding the conversion date.

	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversions feature of $175,081 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of September 30, 2013 is $250,000. During the year ended December 31, 2012, the Company recorded a gain on the change in fair value of the conversion option derivative liability of $150,981 and as of September 30, 2013, the fair value of the conversion option derivative liability was $nil.

	(b) On April 13, 2010, the Company entered into a $250,000 draw down promissory note agreement with a non-related party. Amounts drawn on this credit facility bear interest at 8% per annum, are unsecured, and were due on April 13, 2011. The holder may convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the thirty trading days immediately preceding the conversion date. On October 14, 2010, the conversion price was changed to be fixed at $0.45 per share.

	As of September 30, 2013, the outstanding balance is $250,000. The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $147,140 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of September 30, 2013 is $250,000. As of December 31, 2012, the fair value of the conversion option derivative liability was $nil.

	(c) Effective January 31, 2005, the former President of the Company entered into a line of credit agreement with a financial institution allowing for borrowings of up to $800,000 with annual interest at prime to be used to fund the operations of the Company. The line of credit is secured by the principal residence of the former President of the Company. Monthly interest-only payments are required. On October 21, 2010, the Company agreed to add a conversion option to the entire balance of principal and interest outstanding at any time on the line of credit. The President of the Company may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the five trading days immediately preceding the conversion date. The maturity date was December 31, 2011.

	As of September 30, 2013, the outstanding balance is $788,469 (December 31, 2012 - $788,469). The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $592,991 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of December 31, 2012 is $788,469. During the year ended December 31, 2012, the Company recorded a gain on the change in fair value of the conversion option derivative liability of $402,315 and as of December 31, 2012, the fair value of the conversion option derivative liability was $nil.

	On August 18, 2011 the company defaulted on the payments owed to the financial institution. As a result, UTP Holdings LLC was obligated to make the monthly bank payments on behalf of the company. UTP Holdings LLC notified the company of the default and the payments. The company is recording the additional amounts due to UTP holdings as a current liability.

	(d) Effective March 18, 2010, the Company entered into a line of credit agreement with a company owned by the former President of the Company allowing for borrowings of up to $150,000 bearing interest at 8% per annum. The line of credit is unsecured and all borrowings plus interest are due on demand. On October 21, 2010, the Company agreed to add a conversion option to the entire balance of principal outstanding at any time on the line of credit. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the five trading days immediately preceding the conversion date.

	The balance on the line of credit as of September 30, 2013 is $50,300. The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $11,523 with an equivalent discount on the convertible debt. During the year ended December 31, 2012, the Company recorded a gain on the change in fair value of the conversion option derivative liability of $27,752 and as of September 30, 2013 the fair value of the conversion option derivative liability was $nil.

	(e) On February 23, 2011, the Company issued an 8% convertible note for proceeds of $37,500 which matured on November 28, 2011. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 61% of the average of the three lowest closing market prices during the ten day trading period immediately preceding the conversion date. On April 5, 2013, the promissory note was converted into 3,750,000 shares of common stock.

	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $37,500 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of September 30, 2013 is $37,500. During the year ended December 31, 2012, the Company recorded a loss on the change in fair value of the conversion option derivative liability of $101,928As a result of the conversion, the remaining derivative liability of $ 149,417 was recorded as additional paid in capital..

	(f) On March 24, 2011, the Company issued an 8% convertible note for proceeds of $27,500 which matured on December 28, 2011. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 61% of the average of the three lowest closing market prices during the ten day trading period immediately preceding the conversion date.

	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $27,500 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of September 30, 2013 is $27,500. During the year ended December 31, 2012, the Company recorded a loss on the change in fair value of the conversion option derivative liability of $74,323. On April 5, 2013, the promissory note was converted into 2,750,000 shares of common stock and as a result the remaining derivative liability of $ 108,928 was recorded to additional paid in capital

	g) On May 25, 2011 the Company issued an 8% convertible note for proceeds of $27,500 which matured on February 27, 2012. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 61% of the average of the three lowest closing market prices during the ten day trading period immediately preceding the conversion date.

	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $27,500 with an equivalent discount on the convertible debt. During the year ended December 31, 2012, $3,208 has been accreted increasing the carrying value of the convertible debt to $27,500. During the year ended December 31, 2012, the Company recorded a loss on the change in fair value of the conversion option derivative liability of $73,424. On April 5, 2013, the promissory note was converted into 2,750,000 shares of common stock and as a result the remaining derivative liability of $ 107,575 was recorded as additional paid in capital.

	(h) On August 31, 2012 the Company issued a 6% convertible note for proceeds of $20,000 which matures on August 30, 2013. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.

	(i) On November 16, 2012 the Company issued a 6% convertible note for proceeds of $66,709 which matures on November 16, 2013. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.

	In May 2012, the Company increased the authorized shares to 500,000,000 consisting of two classes to be designated as common stock and preferred stock. The total number of common stock shares authorized was increased to 400,000,000 and preferred stock shares totaling 100,000,000 were authorize

	The Company entered in to a consultancy agreement with DeBondo Capital on January 7, 2013 to pay a sum of $50,000 to DeBondo for services to be provided during the first 4-5 months of 2013. DeBondo agreed to convert the fees due to a convertible loan in the amount of $50,000. The note matures on January 8, 2014 and bears interest at 5%. The holder of this note shall have the right, exercisable in whole or in part, to convert the outstanding principle and accrued interest hereunder into fully paid and non-assessable common shares of the Borrower's stock at fair market value.

	On February 4, 2013, the Company signed a promissory note with DeBondo Capital Limited in the amount of $4,000. The note matures on February 4, 2014 and bears interest at 5%. The holder of this note shall have the right, exercisable in whole or in part, to convert the outstanding principle and accrued interest hereunder into fully paid and non-assessable common shares of the Borrower's stock at fair market value.

	On March 12, 2013, the Company signed a promissory note with Laurag Associates S.A. in the amount of $2,500. The note matures March 13, 2014 and bears interest at 5%. The holder of this note shall have the right, exercisable in whole or in part, to convert the outstanding principle and accrued interest hereunder into fully paid and non-assessable common shares of the Borrower's stock at fair market value.

Promissory_Notes

Promissory Notes	9 Months Ended
Promissory Notes	Sep. 30, 2013
Convertible Notes Payable [Abstract]	'
PROMISSORY NOTES	'
	NOTE 4 – PROMISSORY NOTES

	On September 10, 2013 and September 24, 2013, the Company signed a promissory notes with Capital Nordic Ltd. in the amounts of $3,000 and $5,000. The notes plus interest of $450 and $750 respectively are payable after 4 months.

	On August 1, 2013, the Company signed a promissory note with De Bondo Capital Limited in the amount of $17,000. The principal amount plus interest of $1,700 is due February 1, 2014.

Common_Stock

Common Stock	9 Months Ended
Common Stock	Sep. 30, 2013
Common Stock [Abstract]	'
COMMON STOCK	'
	NOTE 5 – COMMON STOCK

	The Company originally had an unlimited number of shares of no par value common stock.

	On inception, the Company issued 10 shares of common stock at £1.00 per share to its founder for total cash proceeds of £10, which converted at its historical rate is $15. The Company closed a share exchange transaction effective March 23, 2013 with the shareholders of Resource Exchange of America Corp. This share exchange transaction constituted a reverse merger and a recapitalization of Allerayde. In conjunction with this reverse merger, the historical accounts of Allerayde become the historical accounts of Resource Exchange of America Corp for accounting purposes. The shareholders of Allerayde were issued 75,872,411 shares of Resource Exchange, representing 98.97% of the issued and outstanding shares of Resource Exchange.

	On January 31, 2013, the Company amended its Articles of Incorporation to increase the total authorized shares of common stock, par value $.0001 per share from 250,000,000 shares to 400,000,000 shares and to additionally authorize a total of 100,000,000 shares of preferred stock, par value $.0001 per share which may be issued by the Company.

	On April 6, 2013, the Company issued 12,346,500 shares of common stock for debt of $95,597.

	As of September 30, 2013 there were 89,005,250 shares of common stock issued and outstanding.

Income_Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2013
Income Taxes [Abstract]	'
INCOME TAXES	'
	NOTE 6 – INCOME TAXES

	As of September 30, 2013, the Company had net operating loss carry forwards of approximately $1,509,506 that may be available to reduce future years’ taxable income arising from the same trade. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

	The provision for corporate income tax at the expected rate of 34% consists of the following for the periods ended September 30, 2013 and 2012:

		2013			2012
	Corporate income tax benefit attributable to:
	Current Operations	$	29,401		$	-
	Less: valuation allowance		(29,401	)		-
	Net provision for Corporate income taxes	$	0		$	0

	The cumulative tax effect at the expected rate of 20% of significant items comprising our net deferred tax amount is as follows as of September 30, 2013:

		2013
	Deferred tax asset attributable to:
	Net operating loss carryover	$	513,340
	Less: valuation allowance		(513,340	)
	Net deferred tax asset	$	0

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2013
Commitments and Contingencies [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 7 – COMMITMENTS AND CONTINGENCIES

	The Company has entered into a lease agreement for its business premises which calls for monthly payments in the amount of approximately £368 through May 31, 2014. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future.

Material_Contracts

Material Contracts	9 Months Ended
Material Contracts	Sep. 30, 2013
Material Contracts [Abstract]	'
MATERIAL CONTRACTS	'
	NOTE 8 – MATERIAL CONTRACTS

	The Company entered in to an agreement effective December 1, 2012 with STFC Innovations Ltd. through the European Space Agency Business Incubation Centre at Harwell. The European Space Agency offers to support projects and ideas for business incubation by providing funding, business and technical assistance as well as office accommodation and services. Allerayde SAB was awarded a grant of £41,500. The first drawdown of £10,350 was paid to Allerayde SAB on February 5, 2013 and two further installments will be paid upon meeting agreed milestones between now and May 14, 2014. Part of the terms of the grant is that Allerayde SAB leases office space at Rutherford Appleton Laboratory, Harwell, Oxfordshire, United Kingdom.

Subsequent_Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2013
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 9 – SUBSEQUENT EVENTS

	In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to September 30, 2013 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2013
Summary of Significant Accounting Policies [Abstract]	'
Development Stage Company	'
	Development Stage Company
	The accompanying financial statements have been prepared in accordance with generally accepted accounting principles related to development-stage companies. A development-stage company is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.
Basis of Presentation	'
	Basis of Presentation
	The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The accompanying interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary in order for the financial statements to be not misleading have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.
Accounting Basis	'
	Accounting Basis
	The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Allerayde considers all highly liquid investments with maturities of three months or less to be cash equivalents. At September 30, 2013 and December 31, 2012, respectively, the Company had $6,093 and $16 of cash.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents, loans payable, and accrued expenses. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.
Income Taxes	'
	Income Taxes
	Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.
Foreign Currency	'
	Foreign Currency
	The operations of the Company are located in England and Wales. Allerayde maintains a Great Britain Pounds bank account. The functional currency is the U.S. Dollar. Transactions in foreign currencies other than the functional currency, if any, are re-measured into the functional currency at the rate in effect at the time of the transaction. Monetary assets and liabilities denominated in Great Britain Pounds are translated into U.S. Dollars at the rate in effect at the balance sheet date. Revenue and expenses denominated in Great Britain Pounds Dollars are translated at the average exchange rate.
Basic Income (Loss) Per Share	'
	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of September 30, 2013.
Stock-Based Compensation	'
	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	Allerayde does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	Sep. 30, 2013
Income Taxes [Abstract]	'
Summary of provision for corporate income tax	'

		2013			2012
	Corporate income tax benefit attributable to:
	Current Operations	$	29,401		$	-
	Less: valuation allowance		(29,401	)		-
	Net provision for Corporate income taxes	$	0		$	0

Summary of deferred income tax assets	'

		2013
	Deferred tax asset attributable to:
	Net operating loss carryover	$	513,340
	Less: valuation allowance		(513,340	)
	Net deferred tax asset	$	0

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Jan. 11, 2012
Summary of Significant Accounting Policies (Textual)	'	'	'	'
Cash and equivalents	$6,093	$16	$0	$0

Going_Concern_Details

Going Concern (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Going Concern (Textual)	'	'
Deficit accumulated during the development stage	($2,687,516)	($3,084)

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	0 Months Ended			3 Months Ended		9 Months Ended		21 Months Ended
Promissory Notes (Details) (USD $)	Sep. 24, 2013	Sep. 10, 2013	Aug. 01, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Promissory Notes (Textual)	'	'	'	'	'	'	'	'
Promissory notes carrrying amount	$5,000	$3,000	$17,000	'	'	'	'	'
Interest expense on debt	$750	$450	$1,700	$2,005	$0	$8,362	$0	$8,362
Promissory notes maturity date	'	'	1-Feb-14	'	'	'	'	'

Convertible_Note_Payable_Detai

Convertible Note Payable (Details) (USD $)

0 Months Ended

9 Months Ended

21 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

Aug. 01, 2013

Jan. 07, 2013

Sep. 30, 2013

Apr. 05, 2013

Jan. 31, 2013

Dec. 31, 2012

Mar. 31, 2011

Feb. 22, 2010

Dec. 31, 2012

Feb. 22, 2010

Sep. 30, 2013

Oct. 14, 2010

Feb. 22, 2010

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Apr. 13, 2010

Jan. 31, 2005

Sep. 30, 2013

Dec. 31, 2012

Mar. 18, 2010

Sep. 30, 2013

Dec. 31, 2012

Mar. 18, 2010

Apr. 06, 2013

Feb. 23, 2011

Sep. 30, 2013

Dec. 31, 2012

Apr. 06, 2013

Mar. 24, 2011

Dec. 31, 2012

Sep. 30, 2013

Apr. 06, 2013

25-May-11

Sep. 30, 2013

Dec. 31, 2012

Aug. 31, 2012

Nov. 16, 2012

Jan. 07, 2013

Feb. 04, 2013

Mar. 12, 2013

Convertible Debt Issuance Condition 1 [Member]

Convertible Debt Issuance Condition 2 [Member]

Convertible Debt Issuance Condition 3 [Member]

Convertible Debt Issuance Condition 4 [Member]

Convertible Debt Issuance Condition 5 [Member]

Convertible Debt Issuance Condition 6 [Member]

Convertible Debt Issuance Condition 7 [Member]

Convertible Debt Issuance Condition 8 [Member]

Convertible Debt Issuance Condition 9 [Member]

Convertible Debt Issuance Condition 10 [Member]

Convertible Debt Issuance Condition 11 [Member]

Promissory note [Member]

Former President [Member]

Non - Related Party [Member]

Former President [Member]

Convertible Note Payable (Textual)

Proceed from issuance of promissory note

$250,000

$4,000

$2,500

Proceeds from promissory note

27,500

37,500

27,500

20,000

66,709

50,000

Debt bearing interest rate at period end

10.00%

8.00%

6.00%

5.00%

Line of credit facility, description

'Equal to 75% of the average of the closing market price of the Company's common stock during the five trading days immediately preceding the conversion date.

'Equal to 75% of the average of the closing market price of the Company's common stock during the thirty trading days immediately preceding the conversion date.

'Equal to 75% of the average of the closing market price of the Company's common stock during the five trading days immediately preceding the conversion date.

'Equal to 61% of the average of the three lowest closing market prices during the ten day trading period immediately preceding the conversion date.

'Equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.

Maturity date

1-Feb-14

31-Dec-11

13-Apr-11

31-Dec-11

28-Nov-11

28-Dec-11

27-Feb-12

30-Aug-13

16-Nov-13

8-Jan-14

4-Feb-14

13-Mar-14

Debt instrument increase conversion price

$0.45

Credit facility amount outstanding

50,300

Estimated fair value of the conversion feature

175,081

147,140

592,991

11,523

37,500

27,500

Carrying value of convertible debt

250,000

788,469

27,500

Gain (loss) due to change in fair value of conversion option

150,981

402,315

27,752

149,417

101,928

74,323

107,575

73,424

Fair value of the conversion option derivative liability

108,928

Number of common stock after conversion of promissory note

2,750,000

Debt conversion, common stock issued

3,750,000

2,750,000

Accretion of discounts on convertible debt

3,208

Maximum borrowing capacity under line of credit facility

800,000

150,000

Common stock authorized

400,000,000

250,000,000

Preferred stock authorized after increment

100,000,000

Consultancy agreement fee

$50,000

Common_Stock_Details

Common Stock (Details)	0 Months Ended	9 Months Ended			21 Months Ended
	Apr. 06, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Jan. 31, 2013	Dec. 31, 2012	Jan. 13, 2012	Mar. 31, 2011
	USD ($)	USD ($)	USD ($)	GBP (£)	USD ($)	USD ($)	USD ($)	Jan. 13, 2012	Mar. 31, 2011
Common Stock (Textual)	'	'	'	'	'	'	'	'	'
Share issued on inception	'	'	'	'	'	'	'	10	'
Issue price per share	'	'	'	£ 1	'	'	'	'	'
Proceeds from issuance of common stock	'	$0	'	£ 0	$15	'	'	'	'
Stock historical rate	'	'	$15	'	'	'	'	'	'
Stock issued to stockholders pursuant to recapitalization of Allerayde	'	'	75,872,411	75,872,411	'	'	'	'	'
Percentage of equity issued	'	'	98.97%	98.97%	'	'	'	'	'
Common stock authorized	'	400,000,000	'	'	400,000,000	400,000,000	'	'	250,000,000
Common Stock, par value	'	$0.00	'	'	$0.00	$0.00	'	'	'
Additional authorized preferred capital	'	'	'	'	'	100,000,000	'	'	'
Preferred Stock, par value per share	'	'	'	'	'	$0.00	'	'	'
Common Stock, shares issued	12,346,500	89,005,250	'	'	89,005,250	'	10	'	'
Common Stock, shares outstanding	'	89,005,250	'	'	89,005,250	'	10	'	'
Debt	$95,597	'	'	'	'	'	'	'	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended		21 Months Ended
Income Taxes (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Corporate income tax benefit attributable to:	'	'	'	'	'	'
Current operations	'	'	'	$29,401	'	'
Less: valuation allowance	'	'	0	-29,401	'	'
Net provision for Corporate income taxes	$0	$0	'	$0	$0	$0

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Sep. 30, 2013
Deferred tax asset attributable to:	'
Net operating loss carryover	$513,340
Less: valuation allowance	-513,340
Net deferred tax asset	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	9 Months Ended
Income Taxes (Details Textual) (USD $)	Sep. 30, 2013
Income Taxes (Textual)	'
Net operating loss carry forwards	$1,509,506
Provision for corporate income tax, expected rate	34.00%
Cumulative tax effect, expected rate	20.00%

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (GBP £)	9 Months Ended
Commitments and Contingencies (Details) (GBP £)	Sep. 30, 2013
Commitments and Contingencies (Textual)	'
Monthly payment of leased premises	£ 368
Lease expiration date	31-May-14

Material_Contracts_Details

Material Contracts (Details) (GBP £)	0 Months Ended	9 Months Ended
Material Contracts (Details) (GBP £)	Feb. 05, 2013	Sep. 30, 2013
Material Contracts (Textual)	'	'
Value of Grant awarded	'	£ 41,500
Grant awards, first installment paid	£ 10,350	'